appears in the following:

Louisiana's Novel 'Subscription' Model For Pricey Hepatitis C Drugs Gains Approval

Wednesday, June 26, 2019

Certain high-cost drugs are straining state budgets. A new deal approved Wednesday allows Louisiana to spend a fixed amount for unlimited access to a costly cure. Other states may try to follow suit.

Comment

In Midst Of Opioid Crisis, FDA May Block New Addiction Drug From Market

Friday, May 24, 2019

A quirk in the law gives an older opioid addiction treatment "orphan drug" status — and a period of exclusive market access. That may prevent some new therapies from reaching patients for years.

Comment

Trump Administration Proposes Rule To Reverse Protections For Transgender Patients

Friday, May 24, 2019

A federal agency issued a proposed rule Friday that rolls back Obama-era protections for transgender patients. Advocates for transgender people say the rule leaves them vulnerable to discrimination.

Comment

Trump Rule Helps Health Care Workers Who Refuse Care For Religious Reasons

Friday, May 03, 2019

The Trump administration is revamping a rule governing discrimination in health-care setting, giving more leeway to providers who object to certain procedures for religious or conscience reasons.

Comment

New Trump Rule Protects Health Care Workers Who Refuse Care For Religious Reasons

Thursday, May 02, 2019

The rule strengthens protections for health care providers who are unwilling to provide services like abortions. Critics say it could put women's health in danger.

Comment

The Issue Of Medicare For All Is Dominating The 2020 Democratic Field

Thursday, April 11, 2019

Several 2020 Democratic candidates support Medicare for All, but what would that proposal look like in action?

Comment

Drug Industry Middlemen To Be Questioned By Senate Committee

Monday, April 08, 2019

The Senate Finance Committee will hear Tuesday from executives from the biggest pharmacy benefit managers. Confidential rebates paid to the PBMs are expected to draw scrutiny.

Comment

Express Scripts Takes Steps To Cut Insulin's Price To Patients

Wednesday, April 03, 2019

As congressional lawmakers continue to turn up the heat on drugmakers, insurers and middlemen over the price of many medicines, one player says it will limit patients' share of the cost of insulin.

Comment

Insulin Is A Major Focus In The Debate Over Rising Prescription Drug Prices

Wednesday, April 03, 2019

Lawmakers in the House and Senate are pressing companies to lower prices for insulin which is essential for many people with diabetes. The price is 10 times higher today than it was 20 years ago.

Comment

Federal Judge Strikes Down Medicaid Work Requirements In Arkansas And Kentucky

Wednesday, March 27, 2019

A federal judge has struck down a Medicaid work requirement in Arkansas and Kentucky. This is a major blow to the Trump administration's vision for the health insurance program for low-income people.

Comment

Justice Department Shifts Policy, Says Entire Affordable Care Act Should Be Overturned

Tuesday, March 26, 2019

The Trump administration's shift in a major legal case against the Affordable Care Act could lead to the reversal of the expansive law and far-reaching effects on all Americans' health care.

Comment

Trump Administration Moves Forward In Attempt To Invalidate Affordable Care Act

Tuesday, March 26, 2019

Justice Department files notice that it agrees with a federal judge's ruling that the ACA should be thrown out. The administration had previously said it wanted only parts of the law invalidated.

Comment

It Will Take More Than Transparency To Reduce Drug Prices, Economists Say

Friday, March 22, 2019

The Trump administration wants to increase transparency in prescription drug pricing. But health economists say the administration's call to tie prices to what other nations pay might work better.

Comment

U.S. Hospitals And Insurers Might Be Forced To Reveal The True Prices They Negotiate

Monday, March 11, 2019

A little-noticed Trump administration proposal would require hospitals, doctors and insurers to post the true, negotiated price for a medical procedure or service, as opposed to the "list" price.

Comment

FDA Commissioner Scott Gottlieb Says He'll Leave The Agency Next Month

Wednesday, March 06, 2019

Scott Gottlieb, head of the Food and Drug Administration, is resigning, effective next month. The reasons for his resignation are not yet clear, but it appears it was not requested by the White House.

Comment

Commissioner Of Food And Drug Administration Announces He Will Resign

Tuesday, March 05, 2019

In a surprise move, the Food and Drug Administration commissioner announced Tuesday he will resign from his position. Dr. Scott Gottlieb is widely viewed as an effective advocate of public health.

Comment

Poll: Americans Support Government Action To Curb Prescription Drug Prices

Friday, March 01, 2019

A new poll by the Kaiser Family Foundation shows that many people struggle to pay for medicines and that a majority of Americans would welcome a range of government interventions to lower prices.

Comment

Leaders Of 7 Pharmaceutical Manufacturers Face Tough Questioning On Capitol Hill

Tuesday, February 26, 2019

The CEOs of seven U.S. drug makers testified before the Senate Finance Committee on their pricing practices.

Comment

Pharmaceutical Company CEOs Face Grilling In Senate Over High Drug Prices

Tuesday, February 26, 2019

Senators called pharmaceutical industry leaders to account for the high costs of medicine during a Senate hearing. The executives deflected blame to insurance companies and middlemen.

Comment

CVS Looks To Make Its Drugstores A Destination For Health Care

Thursday, February 21, 2019

With almost 10,000 stores across the country, CVS says it is already where consumers are. The company is transforming some of its stores and their retail clinics into hubs for a wider range of care.

Comment